DCF — CROCKETT MEDICAL CENTER
Enterprise Value: $-32.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-32.5M
Enterprise Value
$-10.2M
PV of Cash Flows
$-22.3M
PV of Terminal Value
$-36.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $16.9M | $-2.1M | -12.0% | $-2.8M | $-2.5M |
| Year 2 | $17.4M | $-2.0M | -11.0% | $-2.7M | $-2.2M |
| Year 3 | $17.9M | $-1.9M | -10.0% | $-2.6M | $-2.0M |
| Year 4 | $18.5M | $-1.8M | -10.0% | $-2.6M | $-1.8M |
| Year 5 | $19.0M | $-1.8M | -10.0% | $-2.6M | $-1.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-32.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$16.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12862109904916888
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5